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an a Message
rom the Dead Save Lives?*
eter J. Schwartz, MD, FACC,
ia Crotti, MD
avia, Italy
ndependently of cause, death of the young is always a
ragedy for those left behind. When a young person’s death
s also sudden and unexplained, the tragedy is compounded
nd often unbearable. Although relatively infrequent, be-
ween 10% and possibly 30% of sudden deaths in the young
emain unexplained after a thorough autopsy (1). Those
utopsy-negative deaths occurring after the first year of life
re often referred to as sudden unexplained death (SUD)
yndrome. This definition distinguishes them from sudden
eaths occurring in the first year of life, defined as sudden
nfant death syndrome (SIDS).
See page 240
For the medical profession, both SUD and SIDS are
ajor challenges. For the parents and siblings of the victims,
hey represent devastating events that in most cases leave an
ndelible mark. When sudden death claims a child, an
dolescent, or a young adult, parents and siblings may search
esperately for years or a lifetime for “ the truth” regarding
hat took their son or daughter. Whatever they come to
ccept as causal, needs to be associated with a mechanism
hey can understand. When the victims are infants, the same
attern is complicated by feelings of guilt, usually without
asis or remedy, especially for the mothers (2).
Absence of structural cardiovascular abnormalities at
utopsy logically suggests a functional disorder, most likely
ne capable of inducing a lethal arrhythmia. Two recent
tudies (3,4), based on cardiologic and clinical evaluations of
amily members of SUD victims, concluded that between
2% and 28% of cases respectively had evidence of inherited
ardiac diseases or of channelopathies (usually long QT
yndrome [LQTS], but also catecholaminergic ventricular
achycardia [CPVT]). This information has provided the
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.u
From the Department of Cardiology, IRCCS Fondazione Policlinico S. Matteo
nd University of Pavia, Pavia, Italy.ationale for seeking postmortem molecular evidence for a
ife-threatening familial disorder in SUD victims.
In this issue of the Journal, Tester and Ackerman (5)
resent compelling data implicating a cardiac channelopa-
hy as the pathogenic basis for 35% of SUDs, with 20% of
utations related to LQTS. They had previously reported
rom the same series that 15% of cases had mutations related
o CPVT1 (6). The present study involved 49 cases of SUD.
he average age at death was 14 years. Molecular screening,
erformed on DNA extracted from either autopsy blood or
rozen tissue, examined the 5 genes traditionally associated
ith LQTS (KCNQ1, KCNH2, SCN5A, KCNE1,
CNE2), the gene for the Tawil-Andersen syndrome
KCNJ2) incorrectly labeled LQT7 by some investigators as
iscussed elsewhere (7), part of the gene ANK2 implicated
n a complex disease improperly called LQT4, and the
pecific mutation on the gene CACNA1C responsible for the
imothy syndrome, also called LQT8 (8). The LQTS
utations were found in 10 SUD cases (20%). Most of
hese mutations are associated with the clinical variant
QT1, the remaining with the variants LQT2 and LQT3.
wo of the 10 are functional polymorphisms known to
onfer arrhythmic risk to a vulnerable host.
Importantly, personal and family history data were avail-
ble for 9 of these 10 SUD cases with genetic mechanisms
mplicating LQTS. In 6 of these cases (67%), sudden death
as the initial event; there were no harbingers. In the
emaining 3 cases there was a personal history of either
yncope or seizures. In addition, 5 of the 9 cases (56%) had
positive family history for cardiac events. Furthermore, the
nvestigators were able to perform confirmatory genetic
esting in relatives of 7 of these 9 cases. It is of considerable
linical significance that mutation carriers were identified in
ll (100%) of these families, for a current total of 23 subjects.
The present study represents one more contribution by
ester and Ackerman (5) to the field of sudden cardiac
eath and its genetic background. In conjunction with their
rior publication (6), they have provided evidence that at
east one-third of sudden and unexplained deaths in the
oung have a genetic origin attributable to 2 life-threatening
onditions, LQTS and CPVT. Their merit lies in having
onducted a methodologically careful study and in not
aving ignored the implications of their results.
This molecular investigation of SUD is the logical coun-
erpart of the work carried out by Tester and Ackerman and
y other investigators in SIDS, another condition in which
he common denominator is a negative autopsy. It is now
ecognized that the origin of SIDS is multifactorial, i.e.,
hat several different causes can lead to the sudden and
nexpected death of an infant. Thirty years ago we (9) had
roposed that among these several causes one of potential
mportance might have been LQTS. The implication was
hat the LQTS-related deaths might have been preventable,
hus reducing the total burden of infant deaths grouped
nder the SIDS umbrella. This hypothesis led to several
s
i
(
L
w
v
t
a
L
v
L
t
t
s
fi
(
T
e
1
i
p
f
g
l
L
h
p
P
c
a
r
b
c
t
o
l
s
e
t
a
t
i
a
t
i
r
i
a
e
d
s
a
t
t
fi
i
L
t
m
l
n
f
w
(
r
f
G
S
s
C
l
p
i
b
s
m
y
v
4
a
n
a
Q
p
5
t
a
h
m
c
i
5
y
t
l
i
A
m
t
s
A
T
248 Schwartz and Crotti JACC Vol. 49, No. 2, 2007
Editorial Comment January 16, 2007:247–9tudies, ranging from epidemiology in a large cohort of
nfants studied prospectively with an electrocardiogram
ECG) (10) to proof-of-concept molecular identification of
QTS-causing mutations in victims of SIDS (11) or infants
ho survived a classic near-miss episode with documented
entricular fibrillation (12). All of these data contributed to
he converging clinical and molecular evidence showing that
t least anecdotal cases of SIDS were indeed caused by
QTS. This was followed by 2 cohort studies in SIDS
ictims. The first, by the present investigators, who reported
QTS-causing mutations in 5.2% of 58 white SIDS vic-
ims, and in 2.9% of 34 black SIDS victims (LQTS seems
o be more rare among black patients) (13,14). A second
tudy, in a cohort of 201 Norwegian SIDS victims, identi-
ed functional mutations in LQTS-related genes in 9.5%
95% confidence interval 5.8 to 14.4) of SIDS victims (15).
he bottom line is that 30 years after the original hypoth-
sis, there is now undeniable evidence that approximately
0% of SIDS victims carry LQTS-related mutations. The
nescapable implication is that these arrhythmic deaths are
reventable if early identification of the infants at risk is
acilitated.
Extending these concepts to the prenatal period, there is
rowing evidence that a fraction—still to be quantified—of
ate stillbirths may result from the same mechanism, namely
QTS-related deaths (16–18). These diagnoses would be
elpful for genetic counseling with the goal of reducing the
robability of additional pregnancies with affected offspring.
reliminary and still unpublished data suggest that espe-
ially SCN5A mutations may contribute to late stillbirths.
What are the logical implications of the study by Tester
nd Ackerman (5)? Two are rather straightforward, and one
equires a more thorough appraisal. Wisely, they have all
een mentioned by the investigators, perhaps a bit too
autiously.
The first is that these findings should lead to changes in
he management of SUD cases. Given the observation that
ne-third of these cases are of genetic origin, it seems no
onger justifiable to ignore genotyping in these victims of
udden death. To find a disease-causing mutation will
nable a rapid screening of all relatives; this should identify
hose who carry the same mutation as the victim. This
pproach should now become part of the routine postmor-
em study of SUD cases. The second and closely related
mplication is the utility and in fact necessity of performing
comprehensive cardiologic evaluation of first-degree rela-
ives. The recognized limitation here is the possibility of
ncomplete penetrance expressed in these diseases (19).
The third implication is not only the most promising and
ational, but also the most controversial. It concerns the
nstitution of a far-flung program of ECG screening. Such
program, originally proposed on the basis of the first solid
vidence linking QT prolongation and risk of SIDS (10),
eserves careful analysis. The main objective of ECG
creening would be the early identification of individuals
ffected by LQTS. Because the most severe cases of LQTS send to have markedly prolonged QT intervals, their iden-
ification would be rather simple.
It seems appropriate to examine first the potential bene-
ts of such a screening and then its feasibility and cost. The
dentification of still-asymptomatic individuals affected by
QTS would allow the early institution of beta-blocker
herapy and the prevention of most life-threatening arrhyth-
ic events. As noted also by Tester and Ackerman (5), a
arge percentage of sudden deaths among LQTS patients is
ot preceded by warning events. The ECG screening of
amily members will identify other affected family members
ith QT prolongation, and genotyping of the proband
with the current rate of success, 70%) would allow the
ecognition of “silent” mutation carriers within the extended
amilies. When should this ECG screening be performed?
iven the conclusive evidence that approximately 10% of
IDS cases are related to LQTS it seems logical, as
uggested by the Task Force of the European Society of
ardiology (20), to screen in the third and fourth weeks of
ife. The objective of the screening would not be the
revention of SIDS, which would be unreasonable based on
ts low prevalence combined with its multifactorial origin,
ut the prevention of LQTS-related deaths, which include
ome occurring in the first few months of life and many
ore occurring in childhood and later on in life, especially
ounger than age 30 years as in the population of SUD
ictims studied by Tester and Ackerman (5).
We have just completed a prospective ECG study on
5,000 infants (21) that has shown both the complete
cceptance by the families and the possibility of identifying
ot only asymptomatic infants affected by LQTS but also
ffected family members. Importantly, among those with a
Tc 470 ms, which accounts for 7 of 1,000 of the entire
opulation, genotyping has identified LQTS mutations in
0%. Furthermore, a few but significant cases of life-
hreatening congenital heart diseases—coarctation of the
orta and anomalous origin of the left coronary artery—that
ad escaped the initial medical visits were identified by the
edical investigations prompted by ECG abnormalities and
ould be corrected by angioplasty or surgery before irrevers-
ble damage or death.
A cost-effective analysis based on Italy, which has
50,000 live births per year, has shown that the cost per
ear-of-life saved by an ECG screening program limited to
he identification of infants affected by LQTS would be very
ow, approximately €11,000 (22).
When all of these considerations are taken into account,
t should become evident that the study by Tester and
ckerman provides the important message that postmortem
olecular screening is useful per se and also because it
hrows new light on feasible ways to reduce avoidable
udden deaths in the young.
cknowledgment
he authors thank Pinuccia De Tomasi for expert editorialupport.
R
D
M
c
R
1
1
1
1
1
1
1
1
1
1
2
2
2
249JACC Vol. 49, No. 2, 2007 Schwartz and Crotti
January 16, 2007:247–9 Editorial Commenteprint requests and correspondence: Dr. Peter J. Schwartz,
epartment of Cardiology, IRCCS Fondazione Policlinico San
atteo, Viale Golgi, 19, 27100 Pavia, Italy. E-mail: pjqt@
ompuserve.com.
EFERENCES
1. Puranik R, Chow CK, Duflou JA, Kilborn MJ, McGuire MA. Sudden
death in the young. Heart Rhythm 2005;2:1277–82.
2. Zerbi Schwartz L. The origin of maternal feelings of guilt in SIDS.
Relationship with the normal psychological reactions of maternity.
Ann N Y Acad Sci 1988;533:132–44.
3. Behr E, Wood DA, Wright M, et al., Sudden Arrhythmic Death
Syndrome Steering Group. Cardiological assessment of first-degree rela-
tives in sudden arrhythmic death syndrome. Lancet 2003;362:1457–9.
4. Tan HL, Hofman N, van Langen IM, van der Wal AC, Wilde AA.
Sudden unexplained death: heritability and diagnostic yield of cardi-
ological and genetic examination in surviving relatives. Circulation
2005;112:207–13.
5. Tester DJ, Ackerman MJ. Postmortem long QT syndrome genetic
testing for sudden unexplained death in the young. J Am Coll Cardiol
2007;49:240–6.
6. Tester DJ, Spoon DB, Valdivia HH, Makielski JC, Ackerman MJ.
Targeted mutational analysis of the RyR2-encoded cardiac ryanodine
receptor in sudden unexplained death: a molecular autopsy of 49
medical examiner/coroner’s cases. Mayo Clin Proc 2004;79:1380–4.
7. Zhang L, Benson DW, Tristani-Firouzi M, et al. Electrocardio-
graphic features in Andersen-Tawil syndrome patients with KCNJ2
mutations: characteristic T-U-wave patterns predict the KCNJ2 ge-
notype. Circulation 2005;111:2720–6.
8. Splawski I, Timothy KW, Sharpe LM, et al. Cav 1.2 calcium channel
dysfunction causes a multisystem disorder including arrhythmia and
autism. Cell 2004;119:19–31.
9. Schwartz PJ. Cardiac sympathetic innervation and the sudden infant
death syndrome. A possible pathogenetic link. Am J Med 1976;60:
167–72.0. Schwartz PJ, Stramba-Badiale M, Segantini A, et al. Prolongation of
the QT interval and the sudden infant death syndrome. N Engl J Med
1998;338:1709–14.
1. Schwartz PJ, Priori SG, Dumaine R, et al. A molecular link between
the sudden infant death syndrome and the long QT syndrome. N Engl
J Med 2000;343:262–7.
2. Schwartz PJ, Priori SG, Bloise R, et al. Molecular diagnosis in a child
with sudden infant death syndrome. Lancet 2001;358:1342–3.
3. Ackerman MJ, Siu BL, Sturner WQ, et al. Postmortem molecular
analysis of SCN5A defects in sudden infant death syndrome. JAMA
2001;286:2264–9.
4. Tester DJ, Ackerman MJ. Sudden infant death syndrome: how
significant are the cardiac channelopathies? Cardiovasc Res 2005;67:
388–96.
5. Arnestad M, Crotti L, Rognum TO. Prevalence of long QT syndrome
gene variants in sudden infant death syndrome. Circulation 2007. In
press.
6. Hoorntje T, Alders M, van Tintelen P, et al. Homozygous premature
truncation of the HERG protein: the human HERG knockout.
Circulation 1999;100:1264–7.
7. Miller TE, Estrella E, Myerburg RJ, et al. Recurrent third-trimester
fetal loss and maternal mosaicism for long-QT syndrome. Circulation
2004;109:3029–34.
8. Schwartz PJ. Stillbirths, sudden infant deaths, and long QT syndrome.
Puzzle or mosaic, the pieces of the jigsaw are being fitted together.
Circulation 2004;109:2930–2.
9. Priori SG, Napolitano C, Schwartz PJ. Low penetrance in the long
QT syndrome. Clinical impact. Circulation 1999;99:529–33.
0. Schwartz PJ, Garson A Jr., Paul T, et al. Guidelines for the
interpretation of the neonatal electrocardiogram. Eur Heart J 2002;
23:1329–44.
1. Goulene K, Stramba-Badiale M, Crotti L, et al. Neonatal electrocar-
diographic screening of genetic arrhythmogenic disorders and congen-
ital cardiovascular diseases: prospective data from 31,000 infants
(abstr). Eur Heart J 2005;26 Suppl:214.
2. Quaglini S, Rognoni C, Spazzolini C, Priori SG, Mannarino S,
Schwartz PJ. Cost-effectiveness of neonatal ECG screening for the
long QT syndrome. Eur Heart J 2006;15:1824–32.
